Next 10 |
2024-05-12 10:00:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. During the first quarter of 2024, the Polen Credit Opportunities Full Discretion Composite returned...
2024-05-12 09:50:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. During the first quarter of 2024, the Polen Credit U.S. Opportunistic High Yield Composite returned...
2024-05-12 00:26:05 ET Aveanna Healthcare Holdings Inc. (AVAH) Q1 2024 Earnings Conference Call May 09, 2024, 10:00 AM ET Company Participants Debbie Stewart - CAO Jeff Shaner - CEO Matt Buckhalter - CFO Conference Call Participants Ben Hendrix - RBC ...
2024-05-09 10:54:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aveanna Healthcare Hldgs (NASDAQ: AVAH ) just reported results for the first quarter of 2024. Aveanna Healthcare Hldgs reported earnings per share of -3 cents. This was ab...
2024-05-09 07:23:55 ET More on Aveanna Healthcare Holdings Aveanna Healthcare Holdings Inc. (AVAH) Q4 2023 Earnings Call Transcript Aveanna Healthcare reports mixed Q4 results; initiates FY24 outlook Seeking Alpha’s Quant Rating on Aveanna Healthcare Holdings ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period ...
ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Management will host 1x1 investor meetings that day. ...
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (E...
ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer an...
News, Short Squeeze, Breakout and More Instantly...
Aveanna Healthcare Holdings Inc. Company Name:
AVAH Stock Symbol:
NASDAQ Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to net loss of $32.0 million in the comparable prior year period ...